GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » Equity-to-Asset

Devyser Diagnostics AB (OSTO:DVYSR) Equity-to-Asset : 0.75 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Devyser Diagnostics AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr374.5 Mil. Devyser Diagnostics AB's Total Assets for the quarter that ended in Mar. 2024 was kr496.6 Mil. Therefore, Devyser Diagnostics AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.75.

The historical rank and industry rank for Devyser Diagnostics AB's Equity-to-Asset or its related term are showing as below:

OSTO:DVYSR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.41   Med: 0.78   Max: 0.92
Current: 0.75

During the past 7 years, the highest Equity to Asset Ratio of Devyser Diagnostics AB was 0.92. The lowest was 0.41. And the median was 0.78.

OSTO:DVYSR's Equity-to-Asset is ranked better than
73.39% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs OSTO:DVYSR: 0.75

Devyser Diagnostics AB Equity-to-Asset Historical Data

The historical data trend for Devyser Diagnostics AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Equity-to-Asset Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.50 0.41 0.91 0.86 0.76

Devyser Diagnostics AB Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.76 0.76 0.76 0.75

Competitive Comparison of Devyser Diagnostics AB's Equity-to-Asset

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devyser Diagnostics AB's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's Equity-to-Asset falls into.



Devyser Diagnostics AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Devyser Diagnostics AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=385.1/510.1
=0.75

Devyser Diagnostics AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=374.5/496.6
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Devyser Diagnostics AB  (OSTO:DVYSR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Devyser Diagnostics AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Devyser Diagnostics AB (OSTO:DVYSR) Business Description

Traded in Other Exchanges
N/A
Address
Instrumentvagen 19, Hagersten, SWE, 126 53
Devyser Diagnostics AB is specialized in the development, manufacture and sale of market-leading genetic diagnostic kits.The products are used for complex DNA testing in the hereditary disease, oncology and post-transplantation monitoring fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB (OSTO:DVYSR) Headlines

No Headlines